Part 5: Unproven cell therapies and the commercialization of cell-based products

Cytotherapy. 2016 Jan;18(1):138-42. doi: 10.1016/j.jcyt.2015.11.001.

¹ Rubius Therapeutics, Cambridge, Massachusetts, USA. Past Chair, International Society for Cellular Therapy (ISCT) Commercialization Committee 2010-2014. Electronic address: rdeans@rubiustx.com.
² Cell Medica Inc., Houston, Texas, USA. Immediate Past ISCT President, 2012-2014, and Chair, ISCT Advisory Board, 2014-2016.
³ Division of Oncology, Laboratory of Cellular Therapy, University of Modena and Reggio Emilia, Modena, Italy. ISCT President 2014-2016, and Chair of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
⁴ TxCell SA, Valbonne-Sophia Antipolis, France. Chair, ISCT Commercialization Committee 2014-2016.

No abstract available